HuGE Literature Finder
Records
1
-
30
| Effect of Clinical and Genetic Factors on the Development of Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG) in Egyptian Patients Receiving Beta-Blockers. Cardiovascular drugs and therapy 2022 Sep . El Gindy Dina M K, Solayman Mohamed H, Khorshid Ramy, Schaalan Mona F, El Wakeel Lamia |
| Genetic forms and pathophysiology of essential arterial hypertension in minor indigenous peoples of Russia. BMC cardiovascular disorders 2020 Apr 20 (1): 169. Mulerova Tatyana, Uchasova Evgenya, Ogarkov Michael, Barbarash Ol |
| ß -Adrenergic Receptor Gene Affects the Heart Rate Response of ß-Blockers: Evidence From 3 Clinical Studies. Journal of clinical pharmacology 2019 May . Shahin Mohamed H, Rouby Nihal El, Conrado Daniela J, Gonzalez Daniel, Gong Yan, Lobmeyer Maximilian T, Beitelshees Amber L, Boerwinkle Eric, Gums John G, Chapman Arlene, Turner Stephen T, Pepine Carl J, Cooper-DeHoff Rhonda M, Johnson Julie |
| Interrelation of cardiovascular risk factors with high albuminury among patients with arterial hypertension living in Mountain Shoriya. Terapevticheskii arkhiv 2019 Mar 91 (1): 71-77. Mulerova ? ?, Filimonov E S, Maksimov S A, Maksimov V N, Voevoda ? I, Ogarkov ? Yu, Ogarkov ? |
| [Genetic Polymorphisms Associated with the Onset of Arterial Hypertension in a Portuguese Population]. Acta medica portuguesa 2018 Oct 31 (10): 542-550. Sousa Ana Célia, Reis Roberto Palma, Pereira Andreia, Borges Sofia, Freitas Ana Isabel, Guerra Graça, Gouveia Sara, Góis Teresa, Nóbrega Lino, Rodrigues Mariana, Henriques Eva, Freitas Sónia, Ornelas Ilídio, Pereira Décio, Brehm António, Mendonça Maria Isab |
| [Left Ventricular Myocardial Hypertrophy as a Result of Arterial Hypertension Among Mountain Shoria Population. The Role of Genetic Polymorphism]. Kardiologiia 2018 Sep (9): 37-46. Barbarash O L, Mulerova T A, Maksimov V N, Chigisova A N, Voevoda M I, Ogarkov M |
| mRNA expression profile in peripheral blood mononuclear cells based on ADRB1 Ser49Gly and Arg389Gly polymorphisms in essential hypertension - a case-control pilot investigation in South Indian population. Clinical chemistry and laboratory medicine 2018 May . Varakantham Varsha, Kurakula Sailoo Ashok Kumar, Nagalla Balakrishna, Bharatraj Dinesh Kum |
| The Association of ADRB1 and CYP2D6 Polymorphisms With Antihypertensive Effects and Analysis of Their Contribution to Hypertension Risk. The American journal of the medical sciences 2018 Mar 355 (3): 235-239. Chen Liping, Xiao Ting, Chen Liling, Xie Shanshan, Deng Maoqing, Wu Dingcha |
| A comparison of the genetic and clinical risk factors for arterial hypertension between indigenous and non-indigenous people of the Shoria Mountain Region. Clinical and experimental hypertension (New York, N.Y. : 1993) 2017 Oct 1-8. Mulerova Tatyana, Ogarkov Michael, Uchasova Evgenya, Voevoda Michael, Barbarash Ol |
| The association of eight potentially functional polymorphisms in five adrenergic receptor-encoding genes with myocardial infarction risk in Han Chinese. Gene 2017 Apr . Xia Kun, Ding Rongjing, Zhang Zhiyong, Li Weiming, Shang Xiaoming, Yang Xinchun, Wang Lefeng, Zhang |
| Pharmacogenetic Associations of ß1-Adrenergic Receptor Polymorphisms With Cardiovascular Outcomes in the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes). Stroke 2017 Mar . Magvanjav Oyunbileg, McDonough Caitrin W, Gong Yan, McClure Leslie A, Talbert Robert L, Horenstein Richard B, Shuldiner Alan R, Benavente Oscar R, Mitchell Braxton D, Johnson Julie |
| The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies. Translational psychiatry 2017 Jan 7 (1): e1007. Amare A T, Schubert K O, Klingler-Hoffmann M, Cohen-Woods S, Baune B |
| Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide Pathway. Hypertension 2016 Jun . Kiranmayi Malapaka, Chirasani Venkat R, Allu Prasanna K R, Subramanian Lakshmi, Martelli Elizabeth E, Sahu Bhavani S, Vishnuprabu Durairajpandian, Kumaragurubaran Rathnakumar, Sharma Saurabh, Bodhini Dhanasekaran, Dixit Madhulika, Munirajan Arasambattu K, Khullar Madhu, Radha Venkatesan, Mohan Viswanathan, Mullasari Ajit S, Naga Prasad Sathyamangla V, Senapati Sanjib, Mahapatra Nitish |
| Association of the ADRB2 (rs2053044) polymorphism and angiotensin-converting enzyme-inhibitor blood pressure response in the African American Study of Kidney Disease and Hypertension. Pharmacogenetics and genomics 2015 Sep 25 (9): 444-9. Anthony Ericha G, Richard Erin, Lipkowitz Michael S, Bhatnagar Vib |
| Associations between ADRB1 and CYP2D6 gene polymorphisms and the response to ß-blocker therapy in hypertension. The Journal of international medical research 2015 Jun 43 (3): 424-34. Wu Dingchang, Li Ganyang, Deng Maoqing, Song Wei, Huang Xiaohua, Guo Xiaoru, Wu Zhengzheng, Wu Shiyang, Xu Jias |
| Association of common polymorphisms in ß1-adrenergic receptor with antihypertensive response to carvedilol. Journal of cardiovascular pharmacology 2014 Oct 64 (4): 306-9. Si Dayong, Wang Juan, Xu Ying, Chen Xiaoshuai, Zhang Mingqiu, Zhou H |
| ß1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: a meta-analysis. Molecular biology reports 2013 Jun 40 (6): 4055-63. Wang Hao, Liu Jielin, Liu Kuo, Liu Ya, Wang Zuoguang, Lou Yuqing, Niu Qiuli, Gu Wei, Wang Lijuan, Li Mei, Zhu Xiaoling, Wen Shaoj |
| G protein receptor kinase 4 polymorphisms: ß-blocker pharmacogenetics and treatment-related outcomes in hypertension. Hypertension 2012 Oct 60 (4): 957-64. Vandell Alexander G, Lobmeyer Maximilian T, Gawronski Brian E, Langaee Taimour Y, Gong Yan, Gums John G, Beitelshees Amber L, Turner Stephen T, Chapman Arlene B, Cooper-DeHoff Rhonda M, Bailey Kent R, Boerwinkle Eric, Pepine Carl J, Liggett Stephen B, Johnson Julie |
| Impact of genomic polymorphism on arterial hypertension after aortic coarctation repair. International journal of cardiology 2011 Aug 151 (1): 63-8. Hager Alfred, Bildau Judith, Kreuder Joachim, Kaemmerer Harald, Hess Jo |
| Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics. Pharmacogenomics 2011 Jun 12 (6): 783-95. Sehrt Daniel, Meineke Ingolf, Tzvetkov Mladen, Gültepe Senol, Brockmöller Jürg |
| ß(1)-adrenergic receptor polymorphisms and response to ß-blockade in the African-American study of kidney disease and hypertension (AASK). American journal of hypertension 2011 Jun 24 (6): 694-700. Lee Jason, Aziz Hossein, Liu Lin, Lipkowitz Michael, O'Connor Daniel T, Richard Erin, Brophy Victoria, Wassel Christina L, Blantz Roland, , Bhatnagar Vib |
| Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals. Hypertension 2011 May 57 (5): 903-10. Johnson Andrew D, Newton-Cheh Christopher, Chasman Daniel I, Ehret Georg B, Johnson Toby, Rose Lynda, Rice Kenneth, Verwoert Germaine C, Launer Lenore J, Gudnason Vilmundur, Larson Martin G, Chakravarti Aravinda, Psaty Bruce M, Caulfield Mark, van Duijn Cornelia M, Ridker Paul M, Munroe Patricia B, Levy Daniel, , , |
| Genetic variants of connexin37 are associated with carotid intima-medial thickness and future onset of ischemic stroke. Atherosclerosis 2011 Jan 214 (1): 101-6. Leu Hsin-Bang, Chung Chia-Min, Chuang Shao-Yuan, Bai Chyi-Huey, Chen Jiunn-Rong, Chen Jaw-Wen, Pan Wen-Ha |
| Haplotypes of the adrenergic system predict the blood pressure response to beta-blockers in women with essential hypertension. Pharmacogenomics 2010 Mar 11 (3): 319-25. Filigheddu Fabiana, Argiolas Giuseppe, Degortes Simona, Zaninello Roberta, Frau Francesca, Pitzoi Silvia, Bulla Emanuela, Bulla Patrizia, Troffa Chiara, Glorioso Nico |
| Synopsis and data synthesis of genetic association studies in hypertension for the adrenergic receptor family genes: the CUMAGAS-HYPERT database. American journal of hypertension 2010 Mar 23 (3): 305-13. Kitsios Georgios D, Zintzaras Eli |
| [Genetic predisposition to development of atrial fibrillation in patients with hypertensive disease]. Kardiologiia 2010 50 (5): 19-24. Gorshkova E S, Minushkina L O, Brovkin A N, Brazhnik V A, Nosikov V V, Zate?shchikov D |
| [Myocardial hypertrophy in patients with hypertensive disease: the role of genetic polymorphism of beta-adrenoreactive structures]. Kardiologiia 2010 50 (1): 9-15. Minushkina L O, Nikitin A G, Brazhnik V A, Brovkin A N, Nosikov V V, Zate?shchikov D |
| Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009 Dec 24 (12): 3677-86. Fung Maple M, Chen Yuqing, Lipkowitz Michael S, Salem Rany M, Bhatnagar Vibha, Mahata Manjula, Nievergelt Caroline M, Rao Fangwen, Mahata Sushil K, Schork Nicholas J, Brophy Victoria H, O'Connor Daniel T, |
| Genetic factors are relevant and independent determinants of antihypertensive drug effects in a multiracial population. American journal of hypertension 2009 Dec 22 (12): 1295-302. van Rijn-Bikker Petra C, Mairuhu Gideon, van Montfrans Gert A, Sijbrands Eric J G, Zwinderman Aeilko H, Guchelaar Henk-Jan, Koopmans Richard |
| [Genetic determinants of hypertension in two national cohorts of Mountain Shoria]. Terapevticheskii arkhiv 0 89 (9): 68-77. Barbarash ? L, Voevoda ? I, Artamonova G V, Mulerova ? ?, Voropaeva ? N, Maksimov V N, Ogarkov ? |
- Page last reviewed:Jul 25, 2022
- Page last updated:Dec 02, 2022
- Content source: